| Fecha | Hora | Fuente | Título | Símbolo | Compañía |
| 03/10/2019 | 16:04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 24/09/2019 | 05:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 23/09/2019 | 16:06 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 13/09/2019 | 16:19 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 27/08/2019 | 09:03 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 16/08/2019 | 16:02 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 14/08/2019 | 16:12 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 23/07/2019 | 08:59 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 17/07/2019 | 16:27 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 11/07/2019 | 16:28 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 03/07/2019 | 09:00 | GlobeNewswire Inc. | Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019 | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/06/2019 | 09:28 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 03/06/2019 | 16:22 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 15/05/2019 | 15:01 | GlobeNewswire Inc. | Ohr Pharmaceutical Reports Financial Results for the Fiscal Second Quarter of 2019 | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 08/03/2019 | 16:21 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 21/02/2019 | 09:45 | GlobeNewswire Inc. | Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 09/01/2019 | 14:45 | PR Newswire (US) | SHAREHOLDER ALERT: WeissLaw LLP Investigates Ohr Pharmaceutical, Inc. | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 04/01/2019 | 06:40 | PR Newswire (US) | LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 03/01/2019 | 09:36 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 31/12/2018 | 15:38 | Edgar (US Regulatory) | Notification That Annual Report Will Be Submitted Late (nt 10-k) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 18/12/2018 | 16:05 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 07/12/2018 | 15:10 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 14/08/2018 | 15:05 | GlobeNewswire Inc. | Ohr Pharmaceutical Reports Fiscal Third Quarter 2018 Financial Results | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 15/05/2018 | 15:05 | GlobeNewswire Inc. | Ohr Pharmaceutical Reports Fiscal Second Quarter 2018 Financial Results | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 13/03/2018 | 06:32 | GlobeNewswire Inc. | Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 15/02/2018 | 16:15 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 14/02/2018 | 15:05 | GlobeNewswire Inc. | Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 06/12/2017 | 14:43 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 18/10/2017 | 17:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |
| 16/05/2017 | 16:05 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:OHRP | Ohr Pharmaceuticals, Inc. |